Additionally, the thrombosis, inflammation, and platelet disorders may affect the ADAMTS13:AC, VWF:Ag, and Et levels in patients with LC [12,45,48]. This evidence concerns the gene ADAMTS13 and laryngotracheoesophageal cleft.